BDI Pharma is Pharmaceuticals in United States that focus on bio-pharmaceutical products business. Founded in 1995. They cover business area such as distributor, specialty, support, customer-centric approach, plasma relate pharmaceutical, ivig infusion therapy, hemophilia factor, albumin, hyper-immune, manufacturer, healthcare provider, patient, critical care pharmaceutical, crucial time.
1995
( 30 years old in 2025 )
Bio-pharmaceutical Products
-
120 Research Drive
Columbia, SC 29203
United States
Private
distributorspecialtysupportcustomer-centric approachplasma relate pharmaceuticalivig infusion therapyhemophilia factoralbuminhyper-immunemanufacturerhealthcare providerpatientcritical care pharmaceuticalcrucial time
* We use standard office opening hours in near BDI Pharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
BDI Pharma is Pharmaceuticals business from United States that founded in 1995 (30 years old in 2025), BDI Pharma business is focusing on Bio-pharmaceutical Products.
BDI Pharma headquarter office and corporate office address is located in 120 Research Drive Columbia, SC 29203 United States.
BDI Pharma was founded in United States.
In 2025, BDI Pharma is currently focus on bio-pharmaceutical products sector.
Above is snippet of Google Trends for "bio-pharmaceutical products" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with BDI Pharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
